Kaiser Health News reporter Carmen Heredia Rodriguez joins the host of “On Point,” Anthony Brooks, to discuss public health officials’ concerns about the increasing use of the drug gabapentin by people addicted to opioids. Gabapentin is not an opioid, and it is approved to treat patients with nerve pain or epilepsy. However, some people are illicitly buying the drug and abusing it to enhance their opioid highs or stave off withdrawal from other drugs.
Heredia Rodriguez wrote about the problem in an earlier story on KHN.
The “On Point” discussion about the drug (cue it up at 39:22) follows a discussion on the show about proposals for a single-payer health system.
“On Point” is produced by WBUR in Boston and distributed by NPR.
Read Full Article (External Site)
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.